We are live on ! Find out more
APM

Avidity Partners Management Portfolio holdings

AUM $936M
1-Year Est. Return 195%
This Fund
S&P 500
This Quarter Est. Return
+45.78%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
AUM
$159M
AUM Growth
Cap. Flow
+$138M
Cap. Flow %
86.65%
Top 10 Hldgs %
52.06%
Holding
33
New
33
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 98.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAS
26
DELISTED
Exact Sciences
EXAS
$2.87M 1.81%
+31,000
New +$2.73M
NGNE icon
27
Neurogene
NGNE
$744M
$2.59M 1.63%
+10,500
New +$1.05M
ACAD icon
28
Acadia Pharmaceuticals
ACAD
$4.38B
$2.31M 1.46%
+54,000
New +$2.35M
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$12.8B
$1.37M 0.86%
+15,000
New +$1.45M
RCKT icon
30
Rocket Pharmaceuticals
RCKT
$376M
$683K 0.43%
+30,000
New +$501K
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$473K 0.3%
+40,000
New +$670K
ARAV
32
DELISTED
Aravive, Inc. Common Stock
ARAV
$410K 0.26%
+30,000
New +$265K
RLMD icon
33
Relmada Therapeutics
RLMD
$550M
$390K 0.25%
+10,000
New +$304K

Similar funds

Avidity Partners Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Avidity Partners Management, which disclosed 33 positions worth $159M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Baxter International: 165,000 shares worth $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets.

  • Avidity Partners Management's largest Q4 2019 buy was Baxter International: 165,000 shares worth $13.8M.
  • Avidity Partners Management's ten largest holdings make up 52% of its $159M portfolio in Q4 2019.
  • Avidity Partners Management disclosed 33 positions in Q4 2019, its first 13F filing on record.

Based on Avidity Partners Management's 13F filing for Q4 2019, filed 14 Feb 2020.